NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune

October 3, 2014

News

No comments

Posted by glycotest

Your feedback is valuable for us. Your email will not be published.

Related News

Glycotest, Inc. Receives $3 Million Second Tranche of $10 Million Series A Financing

November 21, 2019

News

New York, NY—November 21, 2019. Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis–cirrhosis, announced today that the Company …

Posted by Webmaster

3 MIN READ

Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine

September 3, 2019

News

Glycotest19-CEOCFOMagazine-Interview.pdf

Posted by Webmaster

1 MIN READ

Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019

August 22, 2019

News

MedTech Innovator Showcase Announcement 6.17.19

Posted by Webmaster

1 MIN READ

GET IN TOUCH

Meet Us

77 Water Street, Suite 817 New York, NY 10005

Give Us A Call

+1 (646) 722-4339

Send Us A Message

info@glycotest.com

Website Designed & Developed by Jason and Company

NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune | Glycotest Diagnostics

NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune

Leave a Comment

Related News

Glycotest, Inc. Receives $3 Million Second Tranche of $10 Million Series A Financing

Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine

Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019

GET IN TOUCH

Meet Us

Give Us A Call

Send Us A Message